C/EBPβ positively regulated the proliferation of various NSCLC cells regardless of NSCLC subtypes or gene mutation status of EGFR or K-RAS, whereas it did not have a substantial effect on immortalized lung epithelial cells (Figure 2). The gene discussed is KRAS; the disease is non-small cell lung carcinoma.